Jul 30, 2026
CSRxP: ETHIC Act & Skinny Labels, Big Savings Act
Two bipartisan solutions — the ETHIC Act and Skinny Labels, Big Savings Act…
© 2026 CSRXP- All Rights Reserved
Resources
Jul 27, 2026
CSRxP: Margin Analysis
SEC filings show that brand name pharmaceutical manufacturers’ profit…
Jul 21, 2026
CSRxP: Senate HELP Fact Sheet
Bipartisan, Market-Based Solution Would Streamline Drug Approval Process and…
Jul 20, 2026
CSRxP: E&C Markup Fact Sheet
How Congress Can Lower Drug Prices, Boost Competition Bipartisan,…
Jun 16, 2026
CSRxP: HELP Preview Biosimilar Fact Sheet
Several bipartisan, market-based solutions that would help foster greater…
Jun 12, 2026
CSRxP: Myth v. Fact
How Congress Can Lower Drug Prices, Boost Competition Trio of Bipartisan…
Jun 11, 2026
CSRxP: Myth vs. Fact
Brand name drug manufacturers game the patent system and drug approval process…
May 29, 2026
CSRxP: Innovation
For far too long, Big Pharma has used the false excuse that research and…
Feb 10, 2026
CSRxP: Statement for the Record
Committee Chairman Guthrie, Committee Ranking Member Pallone, Subcommittee…
Jan 13, 2026
CSRxP: Margin Analysis
Pharmaceutical manufacturers’ profit margins are 10 times larger than other…